(19)
(11) EP 0 973 753 A2

(12)

(88) Date of publication A3:
14.01.1999

(43) Date of publication:
26.01.2000 Bulletin 2000/04

(21) Application number: 98913401.0

(22) Date of filing: 07.04.1998
(51) International Patent Classification (IPC)7C07D 239/80, C07D 401/06, C07D 405/06, C07D 409/06, C07D 413/06, C07D 417/06, C07D 403/06, A61K 31/505
(86) International application number:
PCT/US9806/733
(87) International publication number:
WO 9845/276 (15.10.1998 Gazette 1998/41)
(84) Designated Contracting States:
AT BE CH DE DK ES FI FR GB GR IE IT LI LU NL PT SE
Designated Extension States:
LT LV RO SI

(30) Priority: 09.04.1997 US 838540
14.01.1998 US 71322 P

(71) Applicant: Du Pont Pharmaceuticals Company
Wilmington, DE 19807 (US)

(72) Inventors:
  • CORBETT, Jeffrey, W.
    Haddon Height, NJ 08035 (US)
  • KO, Soo, Sung
    Hockessin, DE 19707 (US)

(74) Representative: Pett, Christopher Phineas et al
Frank B. Dehn & Co.,European Patent Attorneys,179 Queen Victoria Street
London EC4V 4EL
London EC4V 4EL (GB)

   


(54) 4,4-DISUBSTITUTED-3,4-DIHYDRO-2(1H)-QUINAZOLINONES USEFUL AS HIV REVERSE TRANSCRIPTASE INHIBITORS